Sarcoidosis Vasculitis and Diffuse Lung Diseases
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.8 | Q3 | 29.0% | 0.500 | Q3 | 60.9% |
| 2024 | 1.8 | Q3 | 36.1% | 0.376 | Q3 | 52.9% |
| 2023 | 1.4 | Q4 | 24.7% | 0.354 | Q3 | 53.8% |
| 2022 | 1.6 | Q4 | 22.6% | 0.519 | Q2 | 67.4% |
| 2021 | 1.8 | Q4 | 40.0% | 0.420 | Q3 | 61.7% |
| 2020 | — | — | 0.250 | Q3 | 44.1% | |
| 2019 | — | — | 0.306 | Q3 | 53.0% | |
| 2018 | — | — | 0.434 | Q3 | 61.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1124-0490
ISSN
2532-179X
region
Western Europe
coverage
1996-2025